Immediate Impact
11 standout
Citing Papers
The Promising Role of Polyphenols in Skin Disorders
2024 Standout
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Works of Xavier Cubiró being referenced
Inhibidores de JAK: usos en dermatología. Parte 2: aplicaciones en psoriasis, dermatitis atópica y otras dermatosis
2021
Sequential paradoxical psoriasiform reaction and sacroiliitis following adalimumab treatment of hidradenitis suppurativa, successfully treated with guselkumab
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Xavier Cubiró | 64 | 31 | 32 | 39 | 20 | 140 | |
| F Loche | 106 | 29 | 36 | 26 | 25 | 196 | |
| Samuel Zagarella | 58 | 33 | 33 | 38 | 18 | 172 | |
| Enrique Gómez de la Fuente | 58 | 21 | 29 | 18 | 32 | 149 | |
| André Cartell | 53 | 19 | 16 | 68 | 27 | 176 | |
| Andrea Carugno | 100 | 24 | 42 | 18 | 31 | 183 | |
| A. Dietrich | 52 | 21 | 24 | 63 | 19 | 198 | |
| C. Occella | 66 | 29 | 19 | 29 | 30 | 171 | |
| Tomás Toledo‐Pastrana | 52 | 8 | 16 | 45 | 18 | 148 | |
| Masahiro Matsunaka | 22 | 26 | 15 | 35 | 16 | 99 | |
| Jennie T. Clarke | 66 | 69 | 41 | 13 | 25 | 194 |
All Works
Login with ORCID to disown or claim papers
Loading papers...